99% Assay Legal Anabolic Steroid Hormones Toremifene Citrate
Détail rapide
Nom du produit: Citrate de torémifène
Autre nom : Fareston
Numéro de registre CAS: 89778-27-8
Formule moléculaire: C26H28ClNO.C6H8O7
Essai: 99%
Apparence: Poudre cristalline blanche.
Forfait : 1kg/sac en papier d'aluminium ou selon les besoins
Minimum order quantity: 10g
Expédition: By express courier
Expédition : leading time Within 24 hours after receiving the payment
Options de paiement: Western union, MoneyGram, T/T
Prix : Négocié
Classe : Qualité pharmaceutique
Date de livraison : 3-5 jours de travail
Application
Toremifene citrate is an oral selective estrogen receptor modulator (SERM) which helps oppose the actions of estrogen in the body.Licensed in the United States under the brand name Fareston,toremifene citrate is FDA-approved for use in advanced (metastatic) breast cancer.It is also being evaluated for prevention of prostate cancer under the brand name Acapodene.
It has already been covered that Toremifene is a SERM,and serves to block Estrogen at various receptor sites in certain tissues within the body (breast tissue in particular). As a layman explanation,Toremifene pretends to be a ‘fake’ Estrogen that occupies Estrogen receptors within breast tissue.With these receptors occupied by Toremifene,real Estrogen cannot perform their jobs there.Toremifene does not reduce total blood plasma levels of Estrogen.In addition to being antagonistic to Estrogen receptors in breast tissue,it is also antagonistic to Estrogen at the hypothalamus gland (this essentially ‘tricks’ the hypothalamus into thinking there is little or no circulating Estrogen levels in the body,causing it to increase its manufacture of Testosterone so that it can utilize aromatization to restore these levels.
Toremifene Citrate Functions:
Toremifene Citrate improved lipid profiles, particularly as an enhancer of high density lipoprotein cholesterol. Toremifene Citrate improved low density lipoprotein cholesterol levels.Both fareston and tamoxifen selective estrogen receptor modulators and equivalent treatments for metastatic breast cancer.No significant differences were found between treatment with either tamoxifen or fareston Treatment of HR-positive patients with either tamoxifen or toremifene is appropriate.In treating idiopathic oligozoospermia, tamoxifen and fareston are roughly equally effective but raloxifene is not.The antiestrogenic effects of SERMs at the hypothalamic level result in a statistically significant increase of gonadotropin levels, which is more marked for tamoxifen and fareston compared with raloxifene
Directeur commercial